Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

Kaiser Permanente acquiring Geisinger, launching new nonprofit

The new entity, Risant Health, will continue growing through acquisitions and the connection of like-minded health systems.

Conifer, Welldoc partner in digital health app

Conifer Health Solutions, a revenue cycle and value-based care solution provider, has teamed up with Welldoc to launch a new digital health app, Conifer Connect.

COVID-19 vaccine vaccination myocarditis heart damage inflammation RSNA imaging radiology cardiology

Global healthcare partnership targets ‘the big catch-up’ vaccination initiative

The initiative aims to reverse the declining trend in childhood vaccination that has been recorded in more than 100 countries since the start of the COVID-19 pandemic.

Thumbnail

Supreme Court upholds full access to abortion pill

The Supreme Court issued a stay on April 21 that keeps mifepristone on the market without restrictions––for now.

Infusion system recalled for possible leaks after multiple complaints

The recall includes more than 1,500 devices distributed to customers from October 2021 to January 2023. 

Thumbnail

OTC Narcan will cost less than $50

The drug's manufacturer said it is working with retailers to get the drug on U.S. shelves and online for purchase by late summer.

bullish investments in healthcare AI

What healthcare AI investors have been saying at HIMSS23

If great power obligates its wielder to exercise great responsibility, those advancing AI in healthcare are up to their necks in duty.

Thumbnail

Supreme Court delays final decision on abortion pill for 2 more days

A common abortion pill, mifepristone, is still in grave danger of being pulled off the market. 

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup